Antiretroviral  	Antiretroviral  	 JJ	B-NP
prophylaxis  	prophylaxis  	 NN	I-NP
for  	for  	 IN	I-NP
sexual  	sexual  	 JJ	I-NP
and  	and  	 CC	O
injection  	injection  	 NN	B-NP
drug  	drug  	 NN	I-NP
use  	use  	 NN	I-NP
acquisition  	acquisition  	 NN	I-NP
of  	of  	 IN	O
HIV  	HIV  	 NNP	B-NP
During  	During  	 IN	O
the  	the  	 DT	O
past  	past  	 JJ	O
few  	few  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
much  	much  	 RB	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
learned  	learned  	 VBN	O
about  	about  	 IN	O
pre-exposure  	pre-exposure  	 JJ	B-NP
prophylaxis  	prophylaxis  	 NNS	I-NP
( 	( 	 -LRB-	O
PrEP 	PrEP 	 NNP	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
HIV  	HIV  	 NNP	B-NP
from  	from  	 IN	O
studies  	studies  	 NNS	O
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
U.S.  	U.S.  	 NNP	O
and  	and  	 CC	O
elsewhere 	elsewhere 	 RB	O
.  	.  	 .	O
A  	A  	 DT	O
review  	review  	 NN	O
and  	and  	 CC	O
summary  	summary  	 NN	O
was  	was  	 VBD	O
conducted  	conducted  	 VBN	O
of  	of  	 IN	O
articles  	articles  	 NNS	O
and  	and  	 CC	O
reports  	reports  	 VBZ	O
published  	published  	 VBN	O
through  	through  	 IN	O
August  	August  	 NNP	O
2012  	2012  	 CD	O
on  	on  	 IN	O
the  	the  	 DT	O
safety  	safety  	 NN	O
and  	and  	 CC	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
PrEP  	PrEP  	 JJ	O
in  	in  	 IN	O
humans 	humans 	 NNS	O
;  	;  	 :	O
U.S.-based  	U.S.-based  	 JJ	O
studies  	studies  	 NNS	O
assessing  	assessing  	 VBG	B-NP
PrEP  	PrEP  	 JJ	I-NP
knowledge 	knowledge 	 NN	I-NP
,  	,  	 ,	O
attitudes 	attitudes 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
use  	use  	 NN	O
among  	among  	 IN	O
at-risk  	at-risk  	 JJ	B-NP
populations  	populations  	 NNS	I-NP
and  	and  	 CC	O
healthcare  	healthcare  	 JJ	B-NP
providers 	providers 	 NNS	I-NP
;  	;  	 :	O
and  	and  	 CC	O
models  	models  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
cost  	cost  	 NN	B-NP
effectiveness  	effectiveness  	 NN	I-NP
of  	of  	 IN	O
PrEP 	PrEP 	 JJ	O
.  	.  	 .	O
PrEP  	PrEP  	 NNP	O
is  	is  	 VBZ	O
generally  	generally  	 RB	O
safe  	safe  	 JJ	O
and  	and  	 CC	O
effective  	effective  	 JJ	O
and  	and  	 CC	O
may  	may  	 MD	O
be  	be  	 VB	O
cost  	cost  	 VBN	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
a  	a  	 DT	O
targeted  	targeted  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
Awareness  	Awareness  	 NNP	O
and  	and  	 CC	O
interest  	interest  	 NN	O
in  	in  	 IN	O
PrEP  	PrEP  	 NNS	O
are  	are  	 VBP	O
increasing 	increasing 	 VBG	O
.  	.  	 .	O
PrEP  	PrEP  	 NNP	O
is  	is  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
new  	new  	 JJ	O
addition  	addition  	 NN	B-NP
to  	to  	 TO	O
HIV  	HIV  	 NNP	B-NP
prevention  	prevention  	 NN	O
services 	services 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
continued  	continued  	 JJ	O
study  	study  	 NN	O
is  	is  	 VBZ	O
warranted 	warranted 	 VBN	O
.  	.  	 .	O
